Progress in Experimental Tumor Research

Progress in Experimental Tumor Research PDF

Author: L. A. Zilber

Publisher:

Published: 2013-05

Total Pages: 496

ISBN-13: 9781258718428

DOWNLOAD EBOOK →

Fortschritte Der Experimentellen Tumorforschung Progres De La Recherche Experimentale Des Tumeurs. Additional Contributors Include B. E. Eddy, M. F. Stanton, V. M. Bergolz And Others.

Breast Cancer Metastasis and Drug Resistance

Breast Cancer Metastasis and Drug Resistance PDF

Author: Aamir Ahmad

Publisher: Springer Nature

Published: 2019-08-27

Total Pages: 427

ISBN-13: 3030203018

DOWNLOAD EBOOK →

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.

Cox-2

Cox-2 PDF

Author: Joseph R. Bertino

Publisher: Karger Medical and Scientific Publishers

Published: 2003-01-01

Total Pages: 300

ISBN-13: 380557536X

DOWNLOAD EBOOK →

Numerous investigators have found increased levels of cyclooxygenase-2 (COX-2) in both premalignant and malignant tissues. Moreover, animals engineered to be COX-2 deficient or treated with a selective COX-2 inhibitor showed reduced tumor formation and growth. The present book reviews these findings suggesting that COX-2 is a valid molecular target for the prevention and treatment of cancer. The first chapters are devoted to the epidemiology of nonsteroidal anti-inflammatory drugs (NSAIDs) and cancer, the pharmacology of COX-2 inhibitors and the regulation of COX-2 expression in human cancers. Besides, the book contains a series of chapters examining the link between COX-2 and cancer in specific organs (e.g. skin, breast, cervix, digestive tract, lung, etc.). Furthermore, several clinical trials assessing the potential of COX-2 inhibitors for preventing and treating cancer are described. The final chapter provides an up-to-date consideration of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. This state-of-the-art publication is recommended reading not only for medical and radiation oncologists, but also for pharmacologists, gastroenterologists and other subspecialists.

Lanterna Rally - Theme by Grace Themes